TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 51 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $53,000 | +381.8% | 56,000 | +366.7% | 0.00% | – |
| Q3 2019 | $11,000 | -77.6% | 12,000 | -77.4% | 0.00% | – |
| Q1 2019 | $49,000 | -94.5% | 53,000 | -94.7% | 0.00% | -100.0% |
| Q1 2018 | $890,000 | -59.8% | 1,000,000 | -50.5% | 0.01% | -58.3% |
| Q4 2016 | $2,216,000 | -63.3% | 2,021,000 | -47.5% | 0.01% | -64.7% |
| Q4 2015 | $6,046,000 | +237.2% | 3,852,000 | +191.4% | 0.03% | +240.0% |
| Q3 2015 | $1,793,000 | +248.8% | 1,322,000 | +251.6% | 0.01% | +233.3% |
| Q4 2014 | $514,000 | -73.9% | 376,000 | -79.7% | 0.00% | -76.9% |
| Q4 2013 | $1,970,000 | – | 1,855,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |